Series F Financing

Advertisement

cGxPJobs Banner

Parabilis Raises $305M to Advance First-in-Class Cancer Therapies

Cambridge, Massachusetts — January 8, 2026 — Parabilis Medicines announced the successful close of an oversubscribed $305 million Series...

By cGxPwire Editor
January 9, 2026

Read More

Advertisement

cGxPJobs

Directory